Have a personal or library account? Click to login
A Comparison of Different Valgancyclovir Formulations in the Universal 6-Month Prophylaxis Against CMV Infection in Renal Transplant Recipients: A Randomized Single-Centre Study Cover

A Comparison of Different Valgancyclovir Formulations in the Universal 6-Month Prophylaxis Against CMV Infection in Renal Transplant Recipients: A Randomized Single-Centre Study

PRILOZI
Volume 40 (2019): Issue 3 (December 2019)
By: Nikolina Basic-Jukic,  Vesna Furic-Cunko,  Tvrtko Hudolin,  Zoran Zimak,  Jason Kirincich and  Zeljko Kastelan  
Open Access
|Feb 2020
DOI: https://doi.org/10.2478/prilozi-2020-0004 | Journal eISSN: 1857-8985 | Journal ISSN: 1857-9345
Journal RSS Feed
Language: English
Page range: 47 - 55
Published on: Feb 27, 2020
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
CMV,
prophylaxis,
generic,
valganciclovire
Related subjects:
Medicine,
Basic medical science,
History and ethics of medicine,
Clinical medicine,
Clinical medicine, other,
Social sciences,
Education,
Education, other

© 2020 Nikolina Basic-Jukic, Vesna Furic-Cunko, Tvrtko Hudolin, Zoran Zimak, Jason Kirincich, Zeljko Kastelan, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 40 (2019): Issue 3 (December 2019)Next article